登录

需要订阅 JoVE 才能查看此. 登录或开始免费试用。

本文内容

  • 摘要
  • 摘要
  • 引言
  • 研究方案
  • 代表性结果
  • 讨论
  • 披露声明
  • 致谢
  • 材料
  • 参考文献
  • 转载和许可

摘要

本研究描述了一种 通过 密度梯度离心 (DGC) 分离和纯化从人类粪便中富集的细菌细胞外囊泡 (BEV) 的方法,从形态、粒径和浓度方面鉴定了 BEV 的物理特性,并讨论了 DGC 方法在临床和科学研究中的潜在应用。

摘要

细菌细胞外囊泡 (BEV) 是来源于细菌的纳米囊泡,在细菌-细菌和细菌-宿主通讯中发挥积极作用,转移从亲本细菌遗传的蛋白质、脂质和核酸等生物活性分子。源自肠道微生物群的BEV在胃肠道内有影响,可以到达远处的器官,从而对生理学和病理学产生重大影响。探索源自人类粪便的BEV的类型、数量和作用的理论研究对于了解肠道微生物群中BEV的分泌和功能至关重要。这些研究也需要改进当前的BEV分离和纯化策略。

本研究通过建立自上而下和自下而上两种密度梯度离心(DGC)模式,优化了BEV的分离纯化过程。BEV的富集分布在分数6至8(F6-F8)中确定。根据颗粒形态、大小、浓度和蛋白质含量评估该方法的有效性。计算颗粒和蛋白质回收率,分析特异性标记物的存在,比较两种DGC模式的回收率和纯度。结果表明,自上而下离心模式具有较低的污染水平,并实现了与自下而上模式相似的回收率和纯度。7 h的离心时间足以达到108 / mg的粪便BEV浓度。

除粪便外,该方法可应用于其他体液类型,并根据成分和粘度的差异进行适当修改。综上所述,该详细可靠的方案将有助于BEV的标准化分离和纯化,从而为后续的多组学分析和功能实验奠定基础。

引言

肠道被广泛认为是人体内微生物群落最丰富的器官,超过 90% 的细菌参与定植和繁殖 1,2。大量证据表明,肠道微生物群调节肠道微环境,同时与远处器官的功能障碍相互作用,主要是通过受损的肠道屏障 3,4。越来越多的证据表明,肠道菌群的失衡与炎症性肠病 (IBD) 的进展之间存在相关性5,6,以及通过肠脑轴5,6,7,8 的认知障碍。细菌产生的细菌细胞外囊泡 (BEV) 在这些病理过程中起着重要作用。

BEV 是封装细菌衍生物的纳米级颗粒,直径范围为 20 至 400 nm。它们已被证明可以促进细菌与其宿主生物之间的相互作用 9,10。尽管它们不可见,但由于它们作为....

研究方案

南方医科大学南方医院伦理委员会批准了这项研究,该研究是在参与者知情同意的情况下进行的。本文采用的所有方法均符合国际人类微生物组标准(IHMS:http://www.microbiome-standards.org/)提供的标准操作指南。所有随后的液体处理程序都必须在生物安全柜或超洁净工作台内进行。

1. 粪便样本的采集和分装

  1. 分发粪便采样器、密封袋和冰盒,并向参与者提供有关如何获取和保存样本的全面说明。
  2. 指示每个参与者使用提供的采样器收集他们的粪便样本,并在 24 小时窗口内将其以 4 °C 的温度运送到实验室。
  3. 在实验室收到后,使用无菌勺将少于 3.5 g 的粪便分装到预先称重的 50 mL 离心管中。在试管上记下粪便样本的重量,以便进行后续的预处理程序。
    暂停点:如果无法立即处理样品,请在适当记号后将样品分配在-80°C下长期储存。

2. 粪便样品制备

  1. 在4°C下冷却500mL磷酸盐缓冲盐水(PBS)。 使用 50 mL 注射器通过 0.22 μm 聚醚砜 (PES) 过滤器将预冷的 PBS 过滤到 10 个 50 mL 离心管中。
  2. 将两个 50 mL 试管放在冰上,每个试管含有 3.5 g 粪便样品。向每个试管中加入 35 mL P....

代表性结果

确定富含BEV的馏分的分布
为了确定富含细菌胞外囊泡(BEV)的组分的分布,建立了一个空白对照以测量OD 340nm处的吸光度值,并根据测量值和碘克沙醇指南计算每个组分的密度(步骤8.1)。 表 2 显示了密度结果,表明 F4 至 F9 级分的密度在通常与细胞外囊泡相关的范围内。这一发现表明,大多数BEV在这些部分中被分离出来,导致将F4-F9定义为BEV的粗略范围。采用透射电?.......

讨论

细菌细胞外囊泡 (BEV) 是细菌分泌的脂质双层纳米颗粒,携带丰富的蛋白质、脂质、核酸和其他生物活性分子,有助于介导细菌的功能效应20。源自肠道的BEV已被证实与炎症性肠病、克罗恩病和结直肠癌等疾病的发展有关,还会影响一般代谢并介导认知功能受损4,16,17,20,21,22,23,24,25,26

披露声明

作者声明没有利益冲突。

致谢

本研究得到了 国家杰出青年科学基金(82025024)、国家自然科学基金重点项目(82230080); 国家重点研发计划(2021YFA1300604);国家自然科学基金(81871735、82272438、82002245);广东省杰出青年自然科学基金(2023B1515020058); 广东省自然科学基金(2021A1515011639); 山东省自然科学基金国家重大基础研究发展计划(ZR2020ZD11); 博士后科学基金(2022M720059);南方医科大学南方医院优秀青年发展计划(2022J001)。

....

材料

NameCompanyCatalog NumberComments
1 % (w/v) glutaraldehyde (prepared from 2.5 % stock solution in deionized water)ACMECAP1126Morphological observation for BEVs using TEM at Step 8.3.3
1 % (w/v) methylcellulose (prepared from original powder in deionized water)Sigma-AldrichM7027Morphological observation for BEVs using TEM at Step 8.3.6
1.5 % (w/v) uranyl acetate (prepared from original powder in deionized water)Polysciences21447-25Morphological observation for BEVs using TEM at Step 8.3.5
1000 μL, 200 μL, 10 μL PipetteKIRGENKG1313, KG1212, KG1011Transfer the solution
5 % (w/v) bovine serum albumin solution (prepared from the original powder in TBST buffer)Fdbio scienceFD0030Used in western blotting for blocking at Step 8.5.6
5 × loading bufferFdbio scienceFD006Used in western blotting and Coomassie brilliant blue stain at Step 8.5.1
75 % (v/v) alcoholLIRCONLIRCON-500 mLSurface disinfection
96-well plateRarA8096Measure the absorbance values 
Anti-Calnexin antibodyAbcamab92573Western blotting (Primary Antibody)
Anti-CD63 antibodyAbcamab134045Western blotting (Primary Antibody)
Anti-CD9 antibodyAbcamab236630Western blotting (Primary Antibody)
Anti-Flagellin antibodySino Biological40067-MM06Western blotting (Primary Antibody)
Anti-Integrin beta 1 antibodyAbcamab30394Western blotting (Primary Antibody)
Anti-LPS antibodyThermo FisherMA1-83152Western blotting (Primary Antibody)
Anti-LTA antibodyThermo Fisher MA1-7402Western blotting (Primary Antibody)
Anti-OmpA antibodyCUSABIOCSB-PA359226ZA01EOD, https://www.cusabio.com/Western blotting (Primary Antibody)
Anti-Syntenin antibodyAbcamab133267Western blotting (Primary Antibody)
Anti-TSG101 antibodyAbcamab125011Western blotting (Primary Antibody)
AutoclaveZEALWAYGR110DPSterilization for supplies and mediums used in the experiment
BalanceMettler ToledoAL104Balance the tube sample-loaded with PBS
Bicinchoninic acid assay Fdbio scienceFD2001Measure protein content of BEVs at Step 8.2
BioRenderBioRenderhttps://app.biorender.comMake the schematic workflow of BEVs isolation and purification showed in Figure 1
Biosafety cabinetHaierHR1200- II B2Peform the procedures about feces sample handling
Centrifuge 5810 R; Rotor F-34-6-38Eppendorf5805000092; 5804727002, adapter: 5804774000Preprocess for BEVs (Step 3)
Chemiluminescence ApparatusBIO-OIOI600SE-MFUsed in western blotting for signal detection at Step 8.5.12
Cytation 5BioTekF01Microplate detector for measuring the absorbance (Step 8.1) and fluorescence (Figure 6) values 
Dil-labled low density lipoproteinACMECAC12038Definition of distribution of interfering components 
Electrophoresis equipmentBio-rad1658033Used in western blotting for protein separation and transfer at Step 8.5.2, 8.5.3, 8.5.5
Enhanced Chemiluminescence kit HRP Fdbio scienceFD8020Used in western blotting for signal detection at Step 8.5.12
Escherichia coli American Type Culture CollectionATCC8739Isolate BEVs as a positive control. Protocol: Dissolve 25 g of the LB powder in 1 L deionized water, and autoclave. Transfer the 800 μL of preserved Escherichia coli into the medium. Cultivate at 37 °C in the incubator shaker. Then centrifuge at 3, 000 × g for 20 min at 4 °C, 12, 000 × g for 30 min at 4 °C, filter the supernatant through 0.22 μm membrane, and perform ultra-speed centrifugation at 160, 000 × g for 70 min at 4 °C. Pellet defined as crude BEVs from Escherichia coli was suspended in 1.2 mL PBS (Step 3, 4).    
Falcon tubes 50 mLKIRGENKG2811Preprocess for BEVs (Step 3)
Feto Protein Staining BufferAbsciab.001.50Coomassie brilliant blue staining at Step 8.5.4
Filter paperBiosharpBS-TFP-070BMorphological observation for BEVs using TEM at Step 8.3 (Blotting the solution)
Formvar/Carbon supported copper grids Sigma-AldrichTEM-FCF200CU50Morphological observation for BEVs using TEM at Step 8.3
HEPES powderMeilunbioMB6078Prepare iodixanol buffers with different concentrations for density gradient centrifugation
HRP AffiniPure Goat Anti-Mouse IgG (H+L)Fdbio scienceFDM007Western blotting (Secondary Antibody)
HRP AffiniPure Goat Anti-Rabbit IgG (H+L)Fdbio scienceFDR007Western blotting (Secondary Antibody)
Incubator shakerQiangwenDHZ-LCultivate Escherichia coli 
Kimwipes™ Delicate Task WipesKimtech Science34155Wipe the inner wall of the ultracentrifuge tube at Step 4.15
LB brothHopebioHB0128Cultivate Escherichia coli 
Low temperature freezer (-80 °C)HaierDW-86L338JStore the samples
MethanolAlalddinM116118Used in western blotting for activating PVDF membrane at Step 8.5.5
Micro tubes 1.5 mLKIRGENKG2211Recover fractions after density gradient centrifugation
Micro tubes 2 mLKIRGENKG2911Recover fractions after density gradient centrifugation
Micro tubes 5 mLBBIF610888-0001Recover fractions after density gradient centrifugation
Microplate reader Thermo Fisher Multiskan MK3Measure protein content of BEVs at Step 8.2
Millipore filter 0.22 μmMerck milliporeSLGP033RBFiltration sterilization; Material: polyethersulfone, PES
NaClGHTECH1.01307.040Density gradient centrifugation solution
NaOHGHTECH1.01394.068Density gradient centrifugation solution (pH adjustment)
Optima™ XPN-100Beckman CoulterA94469Ultracentrifugation for BEVs isolation at Step 4, 7
OptiPrep™Serumwerk Bernburg AG1893Density gradient centrifugation stock solution
Orbital ShakerYouningCS-100Dissolve feces at Step 2
Phosphate buffered salineProcellPB180327Dissolve feces at Step 2
PipettorEppendorf3120000267, 3120000259Transfer the solution
Plastic pasteur pipetteABCbioABC217003-4Remove supernatant in preprocessing at Step 3.4
Polyvinylidene difluoride (PVDF) membranesMilliporeISEQ00010, IPVH00010Used in western blotting for protein transfer at Step 8.5.5
Prefabricated polyacrylamide gel, 4–20% 15 WellsACEF15420GelUsed in western blotting for protein separation at Step 8.5.2, 8.5.3
Primary antibody diluentFdbio scienceFD0040Used in western blotting at Step 8.5.8
Protein ladderFdbio scienceFD0672Used in western blotting and Coomassie brilliant blue stain at Step 8.5
Rapid protein blotting solutionUBIOUW0500Used in western blotting for protein transfer at Step 8.5.5
Rotor SW 32 Ti Swinging-Bucket RotorBeckman Coulter369650Ultracentrifugation for BEVs isolation at Step 4, 7
Syringe 20 mL, 50 mL JetwayZSQ-20ML, YCXWJZSQ-50 mLTransfer buffers amd remove supernatant in preprocessing
TBS powderFdbio scienceFD1021Used in western blotting at Step 8.5
Transmission electron microscope (TEM)Hitachi H-7650Morphological observation for BEVs at Step 8.3
Tween-20Fdbio scienceFD0020Used in western blotting at Step 8.5
Ultracentrifuge tubeBeckman326823, 355642Ultracentrifugation for BEVs isolation at Step 4, 7
Ultra-clean benchAIRTECHSW-CJ-2FDPeform the procedures about liquid handling
Water bathBluepardCU600Used for measuring protein content of BEVs at Step 8.2.5
ZetaViewParticle MetrixS/N 21-734, Software ZetaView (version 8.05.14 SP7)Nanoparticle tracking analysis (NTA) for measuring the particle size and concentrarion of BEVs at Step 8.4

参考文献

  1. Costello, E. K., et al. Bacterial community variation in human body habitats across space and time. Science. 326 (5960), 1694-1697 (2009).
  2. Greenhalgh, K., Meyer, K. M., Aagaard, K. M., Wilmes, P.

转载和许可

请求许可使用此 JoVE 文章的文本或图形

请求许可

探索更多文章

This article has been published

Video Coming Soon

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。